Mastitis costs Kiwi farmers at least $200 million every year. With increasing incentives to reduce somatic cell counts and new regulations on antibiotic use, farmers need a better solution to identify cows with mastitis so they can treat it with greater accuracy and speed. Current mastitis detection products are either slow or complex.

Bovonic has developed Quadsense, a novel, inline milk sensor technology that enables farmers to enhance animal health, impact, and profits by detecting mastitis in real-time. Its design is purposefully robust and streamlined, allowing farmers to install it themselves into any milking cups around the world. This is revolutionising how farmers test for this costly disease, which will not only boost production and profits, but also improve animal health and reduce antibiotic use, emissions, and farmer stress.

This Tauranga company was founded in early 2021 by Liam Kampshof on his return from London, where he worked for four years in medical device product development. Liam was raised on dairy farms in the Waikato and Bay of Plenty, so has used this experience in product development and background in dairy to develop Quadsense.

Following several initial prototypes QuadSense officially launched at National Fieldays in June 2024 and in less than a year more than 1,600 units have been installed on New Zealand dairy farms, delivering immediate benefits such as reduced bulk somatic cell counts, improved herd health, and time savings for farmers.

To accelerate growth and meet customer support capacity, the Bovonic team has expanded to 6 and the company has begun to build a national distribution network, already signing three milking machine dealers by in March 2025. Internationally, the company has launched five trial farms in the UK and Ireland, exhibited at trade shows, met with potential distributors, and prepared the groundwork for establishing a UK subsidiary in late 2025. They have filed their patent product across all relevant markets.

Bovonic is currently raising capital to support international expansion and continue product development and key hires.

Enterprise Angels first invested in Bovonic in May 2024 and it is part of the EA Fund 4 investment portfolio.

View the investor notes.